Protection against endotoxin shock and impaired glucose homeostasis with ATP
- PMID: 336238
Protection against endotoxin shock and impaired glucose homeostasis with ATP
Abstract
ATP-Mg++ (10 mumoles/100 g, iv) increased the LD50 for Salmonella enteritidis lipopolysaccharide (endotoxin) in male Holtzman rats (300 +/- 10 g) from 1.3 to 6.0 mg/rat. While endotoxin at 3 mg/rat iv 5 hr previously induced hypoglycemia to 12 +/- 4 mg/dl, ATP cotreatment blunted the hypoglycemia; i.e., plasma glucose values were 78 +/- 6 mg/dl. ATP treatment prevented the depression in gluconeogenesis induced by endotoxin as evaluated in vivo by the conversion of 14C-alanine to 14C-glucose. ATP treatment also reduced the hypercatabolism of U-14 C-glucose to 14CO2 in vivo and by epididymal fat pads in vitro. A role for ATP in preventing disruption of glucose homeostasis and development of endotoxin shock via counteracting insulin is suggested.
Similar articles
-
Dexamethasone antagonism of glucose dyshomeostasis in endotoxin shock.Circ Shock. 1978;5(3):317-23. Circ Shock. 1978. PMID: 280423
-
Increased insulin responsiveness in endotoxicosis.Circ Shock. 1979;6(1):1-6. Circ Shock. 1979. PMID: 378453
-
Effect of diltiazem on altered glucose regulation during endotoxic shock.J Surg Res. 1993 Aug;55(2):201-4. doi: 10.1006/jsre.1993.1130. J Surg Res. 1993. PMID: 8412100
-
Galactosamine alters glucose regulation in ten-day-old rats treated with a low dose of endotoxin.Res Commun Mol Pathol Pharmacol. 1996 Mar;91(3):297-302. Res Commun Mol Pathol Pharmacol. 1996. PMID: 8829769
-
Depression of hepatic gluconeogenesis and the hypoglycemia of endotoxin shock.Am J Physiol. 1974 Oct;227(4):778-81. doi: 10.1152/ajplegacy.1974.227.4.778. Am J Physiol. 1974. PMID: 4611233 No abstract available.
Cited by
-
Inhibition of cancer growth and selective glutathione depletion in Ehrlich tumour cells in vivo by extracellular ATP.Biochem J. 1994 Feb 15;298 ( Pt 1)(Pt 1):99-105. doi: 10.1042/bj2980099. Biochem J. 1994. PMID: 8129737 Free PMC article.
-
Adenosine triphosphate: established and potential clinical applications.Drugs. 1999 Aug;58(2):211-32. doi: 10.2165/00003495-199958020-00002. Drugs. 1999. PMID: 10473017 Review.